Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1861)
Xenon Pharmaceuticals Inc. (XENE)
DiFabio Andrea — Chief Legal Officer
Shares
1,342
Price
$55.23
Total Value
$74.11K
Shares Held After
7,301
% of Holdings
15.5%
STAAR SURGICAL CO (STAA)
BROADWOOD PARTNERS, L.P. — Director
Shares
316,017
Price
$18.61
Total Value
$5.88M
Shares Held After
16,123,842
% of Holdings
2.0%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
11,943
Price
$27.16
Total Value
$324.34K
Shares Held After
65,925
% of Holdings
15.3%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
61,253
Price
$26.17
Total Value
$1.60M
Shares Held After
77,868
% of Holdings
44.0%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
12,068
Price
$27.13
Total Value
$327.44K
Shares Held After
62,085
% of Holdings
16.3%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
107,961
Price
$26.15
Total Value
$2.82M
Shares Held After
74,153
% of Holdings
59.3%
ANI PHARMACEUTICALS INC (ANIP)
Cook Meredith — SR. VP, GENERAL COUNSEL & SEC.
Shares
500
Price
$72.62
Total Value
$36.31K
Shares Held After
79,390
% of Holdings
0.6%
ANI PHARMACEUTICALS INC (ANIP)
Mutz Christopher — HEAD OF RARE DISEASE
Shares
3,162
Price
$71.64
Total Value
$226.53K
Shares Held After
91,309
% of Holdings
3.3%
UNIVERSAL HEALTH SERVICES INC (UHS)
SUSSMAN ELLIOT J MD MBA — Director
Shares
356
Price
$193.37
Total Value
$68.84K
Shares Held After
6,113
% of Holdings
5.5%
Indivior Pharmaceuticals, Inc. (INDV)
Ryan Barbara — Director
Shares
8
Price
$31.09
Total Value
$248.68
Shares Held After
5,724
% of Holdings
0.1%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
370,000
Price
$5.00
Total Value
$1.85M
Shares Held After
0
% of Holdings
100.0%
Elevance Health, Inc. (ELV)
SCHULMAN AMY W — Director
Shares
26
Price
$287.50
Total Value
$7.47K
Shares Held After
218
% of Holdings
10.7%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
100
Price
$195.32
Total Value
$19.53K
Shares Held After
2,310,772
% of Holdings
0.0%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
4,082
Price
$194.57
Total Value
$794.22K
Shares Held After
2,310,872
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
7,043
Price
$193.58
Total Value
$1.36M
Shares Held After
2,314,954
% of Holdings
0.3%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
8,579
Price
$192.79
Total Value
$1.65M
Shares Held After
2,321,997
% of Holdings
0.4%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
9,896
Price
$191.55
Total Value
$1.90M
Shares Held After
2,330,576
% of Holdings
0.4%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
22,063
Price
$190.53
Total Value
$4.20M
Shares Held After
2,340,472
% of Holdings
0.9%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
2,886
Price
$189.64
Total Value
$547.31K
Shares Held After
2,362,535
% of Holdings
0.1%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
6,451
Price
$188.52
Total Value
$1.22M
Shares Held After
2,365,421
% of Holdings
0.3%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
5,809
Price
$187.52
Total Value
$1.09M
Shares Held After
2,371,872
% of Holdings
0.2%
Natera, Inc. (NTRA)
Rabinowitz Matthew — Director
Shares
8,091
Price
$186.75
Total Value
$1.51M
Shares Held After
2,377,681
% of Holdings
0.3%
CERUS CORP (CERS)
Jayaraman Vivek K — Chief Operating Officer
Shares
165,200
Price
$1.66
Total Value
$273.77K
Shares Held After
1,747,674
% of Holdings
8.6%
CERUS CORP (CERS)
Green Kevin Dennis — Chief Financial Officer
Shares
127,544
Price
$1.66
Total Value
$211.37K
Shares Held After
1,040,551
% of Holdings
10.9%
CERUS CORP (CERS)
Benjamin Richard J — Chief Medical Officer
Shares
101,740
Price
$1.66
Total Value
$168.60K
Shares Held After
777,361
% of Holdings
11.6%
CERUS CORP (CERS)
Greenman William Mariner — Director
Shares
447,757
Price
$1.66
Total Value
$742.02K
Shares Held After
4,998,493
% of Holdings
8.2%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,299
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,301
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
300
Price
$70.15
Total Value
$21.05K
Shares Held After
4,458,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,815
Price
$69.29
Total Value
$402.93K
Shares Held After
4,458,747
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,885
Price
$68.47
Total Value
$950.69K
Shares Held After
4,464,562
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
300
Price
$70.15
Total Value
$21.05K
Shares Held After
655,686
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,363
Price
$69.32
Total Value
$371.75K
Shares Held After
655,986
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
14,337
Price
$68.48
Total Value
$981.81K
Shares Held After
661,349
% of Holdings
2.1%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Title: Chief Technology and Manufacturing Officer
Shares
10,076
Price
$2.55
Total Value
$25.68K
Shares Held After
515,427
% of Holdings
1.9%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
7,043
Price
$2.55
Total Value
$17.95K
Shares Held After
507,261
% of Holdings
1.4%
Surgery Partners, Inc. (SGRY)
Baldock Jennifer — Chief Admin & Dev Officer
Shares
5,798
Price
$13.17
Total Value
$76.36K
Shares Held After
326,474
% of Holdings
1.7%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.37
Total Value
$173.75K
Shares Held After
82,489
% of Holdings
7.1%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Hudson Frederick M. — Director
Shares
5,369
Price
$50.61
Total Value
$271.73K
Shares Held After
60,413
% of Holdings
8.2%
CASTLE BIOSCIENCES INC (CSTL)
Juvenal Tobin W — Chief Commercial Officer
Shares
20,863
Price
$25.24
Total Value
$526.58K
Shares Held After
86,825
% of Holdings
19.4%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
306
Price
$99.12
Total Value
$30.33K
Shares Held After
70,708
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
5,505
Price
$98.44
Total Value
$541.91K
Shares Held After
71,014
% of Holdings
7.2%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
24,189
Price
$97.79
Total Value
$2.37M
Shares Held After
76,519
% of Holdings
24.0%
ZIMMER BIOMET HOLDINGS, INC. (ZBH)
Winkler Lori — SVP and CHRO
Shares
2,650
Price
$94.66
Total Value
$250.85K
Shares Held After
10,224
% of Holdings
20.6%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
6,453
Price
$21.90
Total Value
$141.32K
Shares Held After
233,369
% of Holdings
2.7%
Privia Health Group, Inc. (PRVA)
Mehrotra Parth — Director
Shares
26,763
Price
$21.90
Total Value
$586.11K
Shares Held After
609,181
% of Holdings
4.2%
Absci Corp (ABSI)
Busch Andreas — Chief Innovation Officer
Shares
100,000
Price
$2.29
Total Value
$229.00K
Shares Held After
421,446
% of Holdings
23.7%
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
Christianson Mark — Business Development Director
Shares
817
Price
$0.80
Total Value
$653.60
Shares Held After
214,383
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
164
Price
$544.58
Total Value
$89.31K
Shares Held After
130
% of Holdings
55.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
356
Price
$543.22
Total Value
$193.39K
Shares Held After
294
% of Holdings
54.8%
Showing 451–500 of 1861 transactions (page 10 of 38)